Singapore markets close in 2 hours 4 minutes

Aurinia Pharmaceuticals Inc. (AUPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.16+0.06 (+1.18%)
At close: 04:00PM EDT
5.09 -0.07 (-1.36%)
After hours: 06:35PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-62,563
-78,020
-108,180
-180,966
-102,680
Depreciation & amortisation
15,777
11,647
2,706
2,761
1,371
Stock-based compensation
41,581
45,311
32,300
31,243
17,454
Change in working capital
-3,115
-5,608
-6,817
-21,633
4,520
Accounts receivable
-9,867
-10,606
1,927
-15,415
-650
Inventory
-8,932
-15,869
-9,072
-5,644
-13,927
Accounts payable
10,917
13,394
699
4,076
-
Other working capital
-20,610
-34,179
-79,821
-159,193
-77,201
Other non-cash items
-173
-1,515
-1,612
9,998
9,477
Net cash provided by operating activities
-20,389
-33,461
-79,529
-157,692
-69,858
Cash flows from investing activities
Investments in property, plant and equipment
-221
-718
-292
-1,501
-7,343
Purchases of investments
-502,363
-523,500
-523,993
-438,958
-202,951
Sales/maturities of investments
532,115
529,376
464,316
354,427
52,108
Other investing activities
-
-11,864
-663
-17,838
-
Net cash used for investing activities
17,667
-6,706
-60,632
-103,870
-158,186
Cash flows from financing activities
Debt repayment
-12,803
-10,025
0
0
-
Common stock issued
-
0
0
196,740
187,732
Net cash used provided by (used for) financing activities
-21,820
-5,130
2,433
221,112
194,375
Net change in cash
-24,542
-45,297
-137,728
-40,450
-33,669
Cash at beginning of period
89,001
94,172
231,900
272,350
306,019
Cash at end of period
64,459
48,875
94,172
231,900
272,350
Free cash flow
Operating cash flow
-20,389
-33,461
-79,529
-157,692
-69,858
Capital expenditure
-221
-718
-292
-1,501
-7,343
Free cash flow
-20,610
-34,179
-79,821
-159,193
-77,201